Company intelligence / Profile preview

Myralis

Valinhos, São Paulo, Brazilindeed.com ↗

Ownership: Private
Development stage: Commercial

Overview

Myralis specializes in the development and distribution of pharmaceutical products with a focus on innovation to improve health and wellbeing. The company has experienced rapid growth, reporting a 40% compound annual growth rate over five years. It has modernized its operations through cloud-based infrastructure to support business expansion

Modalities: small moleculesgenerics
Industry: Biotech

Drug pipeline

5 assets

Mecobe

Unknown

4 more assets in the full pipeline.

Request access →

Partnerships

SantoDigital (for cloud migration/IT infrastructure)

Beyond the preview

Go deeper on Myralis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Myralis.

Explore the full profile